Continuous Data Pipelines vs. Point-in-Time Diagnostics: CEO Jake Donoghue Talks AI and EEG on unNatural Selection

Beacon Biosignals

Beacon Biosignals CEO Jake Donoghue speaks with unNatural Selection, produced in partnership with Mass General Brigham ahead of the World Medical Innovation Forum, on how continuous EEG data pipelines are reshaping neurological diagnostics beyond single point-in-time testing.

Say hello to Waveband!

New name, same FDA 510(k) clearance.

The Dreem 3S EEG headband is now called Waveband, delivering the same trusted technology used by the world’s best companies. Contact us to learn how Waveband can support your clinical trial today.

Share this post:

Say hello to Waveband!

New name, same FDA 510(k) clearance.

The Dreem 3S EEG headband is now called Waveband, delivering the same trusted technology used by the world’s best companies. Contact us to learn how Waveband can support your clinical trial today.

Say hello to Waveband!

New name, same FDA 510(k) clearance.

The Dreem 3S EEG headband is now called Waveband, delivering the same trusted technology used by the world’s best companies. Contact us to learn how Waveband can support your clinical trial today.

Say hello to Waveband!

New name, same FDA 510(k) clearance.

The Dreem 3S EEG headband is now called Waveband, delivering the same trusted technology used by the world’s best companies. Contact us to learn how Waveband can support your clinical trial today.